NumerixS Investment Technologies’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,780
| Closed | -$461K | – | 537 |
|
|
2020
Q2 | $461K | Sell |
3,780
-1,600
| -30% | -$195K | 0.13% | 181 |
|
|
2020
Q1 | $466K | Sell |
5,380
-3,320
| -38% | -$288K | 0.24% | 90 |
|
|
2019
Q4 | $935K | Buy |
8,700
+5,800
| +200% | +$623K | 0.18% | 119 |
|
|
2019
Q3 | $261K | Buy |
2,900
+1,700
| +142% | +$153K | 0.07% | 314 |
|
|
2019
Q2 | $101K | Buy |
+1,200
| New | +$101K | 0.03% | 600 |
|
|
2019
Q1 | – | Sell |
-3,300
| Closed | -$226K | – | 1254 |
|
|
2018
Q4 | $226K | Buy |
3,300
+1,416
| +75% | +$97K | 0.07% | 306 |
|
|
2018
Q3 | $227K | Sell |
1,884
-216
| -10% | -$26K | 0.04% | 537 |
|
|
2018
Q2 | $204K | Buy |
2,100
+1,000
| +91% | +$97.1K | 0.05% | 515 |
|
|
2018
Q1 | $91K | Buy |
+1,100
| New | +$91K | 0.02% | 685 |
|
|
2017
Q1 | – | Sell |
-27,200
| Closed | -$1.05M | – | 1295 |
|
|
2016
Q4 | $1.05M | Buy |
27,200
+19,600
| +258% | +$759K | 0.13% | 199 |
|
|
2016
Q3 | $385K | Sell |
7,600
-4,466
| -37% | -$226K | 0.05% | 455 |
|
|
2016
Q2 | $548K | Buy |
12,066
+3,517
| +41% | +$160K | 0.08% | 365 |
|
|
2016
Q1 | $338K | Buy |
+8,549
| New | +$338K | 0.04% | 601 |
|